Andrew Rasdal - President, Obalon Therapeutics Inc

As of June 25, 2020


Andrew Rasdal Net Worth

  • Net worth is estimated to be at least $4.81M
  • Owns at least 77,892 units of Obalon Therapeutics Inc stock

Andrew Rasdal Trading

  • Largest purchase of shares was 12,500 units , worth over $50K on August 8, 2019
  • In total has made about 9 transactions over 4 years
  • Usually trades in August, January, November and May, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Andrew Rasdal Mailing Address

  • Mailing address is C/o Dexcom, Inc. 5555 Oberlin Drive San Diego CA 92121 CA

Obalon Therapeutics Inc Insider Trading

  • The most recent transaction was 65,000 units bought on November 14, 2019 by William J Plovanic worth over $107.82K
  • In the last 3 years, insiders at Obalon Therapeutics Inc sold an estimated value of $10K and bought an estimated value of $7.97M
  • The most active traders are William J Plovanic,  Amy Vandenberg, Chief Clinical & Reg Officer,  and Mark Brister, Chief Technology Officer
  • Insider trading is most common in August, with the busiest year in 2018

OBALON THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1